These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 23433249)

  • 1. Optical imaging correlates with magnetic resonance imaging breast density and reveals composition changes during neoadjuvant chemotherapy.
    O'Sullivan TD; Leproux A; Chen JH; Bahri S; Matlock A; Roblyer D; McLaren CE; Chen WP; Cerussi AE; Su MY; Tromberg BJ
    Breast Cancer Res; 2013 Feb; 15(1):R14. PubMed ID: 23433249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffuse optical spectroscopic imaging reveals distinct early breast tumor hemodynamic responses to metronomic and maximum tolerated dose regimens.
    Tank A; Peterson HM; Pera V; Tabassum S; Leproux A; O'Sullivan T; Jones E; Cabral H; Ko N; Mehta RS; Tromberg BJ; Roblyer D
    Breast Cancer Res; 2020 Mar; 22(1):29. PubMed ID: 32169100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing tumor contrast in radiographically dense breast tissue using Diffuse Optical Spectroscopic Imaging (DOSI).
    Leproux A; Durkin A; Compton M; Cerussi AE; Gratton E; Tromberg BJ
    Breast Cancer Res; 2013; 15(5):R89. PubMed ID: 24066941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sample size and power determination when limited preliminary information is available.
    McLaren CE; Chen WP; O'Sullivan TD; Gillen DL; Su MY; Chen JH; Tromberg BJ
    BMC Med Res Methodol; 2017 Apr; 17(1):75. PubMed ID: 28446127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffuse optical spectroscopic imaging correlates with final pathological response in breast cancer neoadjuvant chemotherapy.
    Cerussi AE; Tanamai VW; Hsiang D; Butler J; Mehta RS; Tromberg BJ
    Philos Trans A Math Phys Eng Sci; 2011 Nov; 369(1955):4512-30. PubMed ID: 22006904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent optical imaging during breast cancer neoadjuvant chemotherapy reveals dynamic tumor physiology in an individual patient.
    Cerussi AE; Tanamai VW; Mehta RS; Hsiang D; Butler J; Tromberg BJ
    Acad Radiol; 2010 Aug; 17(8):1031-9. PubMed ID: 20542448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting Responses to Neoadjuvant Chemotherapy in Breast Cancer: ACRIN 6691 Trial of Diffuse Optical Spectroscopic Imaging.
    Tromberg BJ; Zhang Z; Leproux A; O'Sullivan TD; Cerussi AE; Carpenter PM; Mehta RS; Roblyer D; Yang W; Paulsen KD; Pogue BW; Jiang S; Kaufman PA; Yodh AG; Chung SH; Schnall M; Snyder BS; Hylton N; Boas DA; Carp SA; Isakoff SJ; Mankoff D;
    Cancer Res; 2016 Oct; 76(20):5933-5944. PubMed ID: 27527559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Near-Infrared Diffuse Optical Imaging for Early Prediction of Breast Cancer Response to Neoadjuvant Chemotherapy: A Comparative Study Using 18F-FDG PET/CT.
    Ueda S; Yoshizawa N; Shigekawa T; Takeuchi H; Ogura H; Osaki A; Saeki T; Ueda Y; Yamane T; Kuji I; Sakahara H
    J Nucl Med; 2016 Aug; 57(8):1189-95. PubMed ID: 26940765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Background parenchymal enhancement in the contralateral normal breast of patients undergoing neoadjuvant chemotherapy measured by DCE-MRI.
    Chen JH; Yu H; Lin M; Mehta RS; Su MY
    Magn Reson Imaging; 2013 Nov; 31(9):1465-71. PubMed ID: 23992630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiparametric monitoring of chemotherapy treatment response in locally advanced breast cancer using quantitative ultrasound and diffuse optical spectroscopy.
    Tran WT; Childs C; Chin L; Slodkowska E; Sannachi L; Tadayyon H; Watkins E; Wong SL; Curpen B; El Kaffas A; Al-Mahrouki A; Sadeghi-Naini A; Czarnota GJ
    Oncotarget; 2016 Apr; 7(15):19762-80. PubMed ID: 26942698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance assessment of diffuse optical spectroscopic imaging instruments in a 2-year multicenter breast cancer trial.
    Leproux A; O'Sullivan TD; Cerussi A; Durkin A; Hill B; Hylton N; Yodh AG; Carp SA; Boas D; Jiang S; Paulsen KD; Pogue B; Roblyer D; Yang W; Tromberg BJ
    J Biomed Opt; 2017 Dec; 22(12):121604. PubMed ID: 29389104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential diagnosis of breast masses in South Korean premenopausal women using diffuse optical spectroscopic imaging.
    Leproux A; Kim YM; Min JW; McLaren CE; Chen WP; O'Sullivan TD; Lee SH; Chung PS; Tromberg BJ
    J Biomed Opt; 2016 Jul; 21(7):74001. PubMed ID: 27436049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal optical monitoring of blood flow in breast tumors during neoadjuvant chemotherapy.
    Cochran JM; Chung SH; Leproux A; Baker WB; Busch DR; DeMichele AM; Tchou J; Tromberg BJ; Yodh AG
    Phys Med Biol; 2017 Jun; 62(12):4637-4653. PubMed ID: 28402286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of neoadjuvant chemotherapy on breast tissue composition: a longitudinal mammographic study with automated volumetric measurement.
    Jang HJ; Kim HJ; Chae YS; Lee SJ; Kim SH; Lee H; Kim WH
    Eur Radiol; 2020 Sep; 30(9):4785-4794. PubMed ID: 32314056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of taxane-based neoadjuvant chemotherapy on fibroglandular tissue volume and percent breast density in the contralateral normal breast evaluated by 3T MR.
    Chen JH; Pan WF; Kao J; Lu J; Chen LK; Kuo CC; Chang CK; Chen WP; McLaren CE; Bahri S; Mehta RS; Su MY
    NMR Biomed; 2013 Dec; 26(12):1705-13. PubMed ID: 23940080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo, noninvasive functional measurements of bone sarcoma using diffuse optical spectroscopic imaging.
    Peterson HM; Hoang BH; Geller D; Yang R; Gorlick R; Berger J; Tingling J; Roth M; Gill J; Roblyer D
    J Biomed Opt; 2017 Dec; 22(12):1-9. PubMed ID: 29264893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the future of diffuse optical imaging technologies for breast cancer management.
    Tromberg BJ; Pogue BW; Paulsen KD; Yodh AG; Boas DA; Cerussi AE
    Med Phys; 2008 Jun; 35(6):2443-51. PubMed ID: 18649477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline tumor oxygen saturation correlates with a pathologic complete response in breast cancer patients undergoing neoadjuvant chemotherapy.
    Ueda S; Roblyer D; Cerussi A; Durkin A; Leproux A; Santoro Y; Xu S; O'Sullivan TD; Hsiang D; Mehta R; Butler J; Tromberg BJ
    Cancer Res; 2012 Sep; 72(17):4318-28. PubMed ID: 22777823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of 7 Tesla breast magnetic resonance imaging determination of intrinsic sensitivity and high-resolution magnetic resonance imaging, diffusion-weighted imaging, and (1)H-magnetic resonance spectroscopy of breast cancer patients receiving neoadjuvant therapy.
    Korteweg MA; Veldhuis WB; Visser F; Luijten PR; Mali WP; van Diest PJ; van den Bosch MA; Klomp DJ
    Invest Radiol; 2011 Jun; 46(6):370-6. PubMed ID: 21317792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of bony anatomic regions in pediatric and adult healthy volunteers using diffuse optical spectroscopic imaging.
    Peterson HM; Tank A; Geller DS; Yang R; Gorlick R; Hoang BH; Roblyer D
    J Biomed Opt; 2020 Aug; 25(8):1-17. PubMed ID: 32790252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.